Fred Locke, MD, Moffitt Cancer Center, explains why this hematologic cancer is such an attractive target for chimeric antigen ...

A study on the long-term safety of CAR T-cell therapy for B-cell lymphoma patients reveals a favourable safety profile with ...

During a Case-Based Roundtable® event, Natalie Galanina, MD, reviewed how outcomes have changed in patients with primary ...

Your B-cell lymphoma has gotten smaller, but it's still there. Usually the cancer has shrunk by half or more. Complete remission. Your doctor can't find any sign of your cancer on scans and other ...

Los Angeles students heading back to class after President's Day will encounter a new mandate: a district-wide cell phone ban that officially takes effect on Tuesday. As approved last June by the ...

Non-Hodgkin's lymphoma ... cell transplant starts with higher doses of chemo and sometimes radiation to kill the cancer cells. But that also kills your bone marrow, which means you can't make ...

Explore CAR-T responses and the challenges of durability in cancer treatment with innovative NKTR-255 interleukin-15 therapy.

Lymphoma is a cancer of the immune system that affects infection-fighting cells ... t eat, can't sleep. One day passes. No call from my doctor." Luckily, the cancer was localized to his ear, which ...

A treatment plan for cutaneous T-cell lymphoma may include one or more of the following types of treatment. To destroy cancer cells found in the skin, you may need to apply medication to your skin, ...

Acknowledging the high rate of relapse after CAR T cell therapy, CAR T cell therapy is a potentially curative option on its own merit, but with careful disease monitoring post, given relapse may need ...